Literature DB >> 26965066

[Apixaban-Related Convexal Subarachnoid Hemorrhage:A Case Report].

Kiyoharu Shimizu1, Kiyoshi Yuki, Takashi Sadatomo, Takeshi Hara, Hideo Ohba, Kaoru Kurisu.   

Abstract

The risk of anticoagulant-associated intracranial hemorrhage(ICH)is relatively low in patients treated with non-vitamin K antagonist oral anticoagulants(NOAC). The anticoagulant-associated ICH comprises mainly intraparenchimal hemorrhage. Subdural hematoma and subarachnoid hemorrhage(SAH)are rare complications after treatment with NOAC, trauma being the most common cause for these two types of ICH. We report a case of non-traumatic convexal SAH(cSAH)associated with Apixavan. A 68-year-old man with repeated history of cerebral embolism with cardiogenic cause presented with weakness of the lower limbs. Magnetic resonance imaging revealed infarctions, and treatment with apixaban(5 mg twice per day)was administered. Three days later, SAH in the right superior frontal sulcus was discovered incidentally on computed tomography(CT). NOAC-associated SAH is a rare manifestation. Cerebral amyloid angiopathy(CAA)is the most common cause of cSAH in the elderly, and cSAH is supposed to be a warning sign of cerebral hemorrhage in CAA. Patients with CAA started on NOAC require careful monitoring.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26965066     DOI: 10.11477/mf.1436203264

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  1 in total

Review 1.  Apixaban-induced subdural bleeding: case presentation and literature review.

Authors:  Eman Alayad; Sami Khairy; Ahmed Aloraidi
Journal:  BMJ Case Rep       Date:  2018-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.